In our study, we initially used GEPIA2, TIMER, and HPA databases to determine the mRNA, protein expression level of IRAK1 in cancers compared normal tissues, and found that its expression was significantly higher in 20 tumours. This evidence concerns the gene IRAK1 and cancer.